Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Moellmann

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Diabetes|August 15, 2018
Glucagon-Like Peptide 1 and Its Cleavage Products Are Renoprotective in Murine Diabetic NephropathyJulia Moellmann, Barbara Mara Klinkhammer, Julia Onstein, et al.
Scientific Reports|August 9, 2018
Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgeryHeidi Noels, Wendy Theelen, Marieke Sternkopf, et al.
Diabetes, Obesity & Metabolism|July 8, 2022
The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosisJulia Moellmann, Pascal A Mann, Ben A Kappel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 3, 2024
GLP-1 in patients with myocardial infarction complicated by cardiogenic shock-an IABP-SHOCK II-substudyMichael Lehrke, Georg Fuernau, Christian Jung, et al.
European Heart Journal|October 18, 2019
Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarctionFlorian Kahles, Marcia V Rückbeil, Robert W Mertens, et al.
Scientific Reports|July 4, 2026
Heart failure promotes gingival inflammation and impairs periodontal remodelingMartin Berger, Marta Rizk, Jaana-Sophia Kern, et al.
Cardiovascular Diabetology|February 6, 2022
The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injuryFlorian Kahles, Matthias Rau, Martin Reugels, et al.
Journal of Clinical Medicine|December 9, 2020
Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial InfarctionElias Haj-Yehia, Robert Werner Mertens, Florian Kahles, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 3, 2023
2,8-Dihydroxyadenine-induced nephropathy causes hexosylceramide accumulation with increased mTOR signaling, reduced levels of protective SirT3 expression and impaired renal mitochondrial functionJulia Moellmann, Katja Krueger, Dickson W L Wong, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 1, 2020
Empagliflozin improves left ventricular diastolic function of db/db miceJulia Moellmann, Barbara M Klinkhammer, Patrick Droste, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Diabetes|August 15, 2018
Glucagon-Like Peptide 1 and Its Cleavage Products Are Renoprotective in Murine Diabetic NephropathyJulia Moellmann, Barbara Mara Klinkhammer, Julia Onstein, et al.
Scientific Reports|August 9, 2018
Reduced post-operative DPP4 activity associated with worse patient outcome after cardiac surgeryHeidi Noels, Wendy Theelen, Marieke Sternkopf, et al.
Diabetes, Obesity & Metabolism|July 8, 2022
The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosisJulia Moellmann, Pascal A Mann, Ben A Kappel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 3, 2024
GLP-1 in patients with myocardial infarction complicated by cardiogenic shock-an IABP-SHOCK II-substudyMichael Lehrke, Georg Fuernau, Christian Jung, et al.
European Heart Journal|October 18, 2019
Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarctionFlorian Kahles, Marcia V Rückbeil, Robert W Mertens, et al.
Scientific Reports|July 4, 2026
Heart failure promotes gingival inflammation and impairs periodontal remodelingMartin Berger, Marta Rizk, Jaana-Sophia Kern, et al.
Cardiovascular Diabetology|February 6, 2022
The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injuryFlorian Kahles, Matthias Rau, Martin Reugels, et al.
Journal of Clinical Medicine|December 9, 2020
Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial InfarctionElias Haj-Yehia, Robert Werner Mertens, Florian Kahles, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 3, 2023
2,8-Dihydroxyadenine-induced nephropathy causes hexosylceramide accumulation with increased mTOR signaling, reduced levels of protective SirT3 expression and impaired renal mitochondrial functionJulia Moellmann, Katja Krueger, Dickson W L Wong, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 1, 2020
Empagliflozin improves left ventricular diastolic function of db/db miceJulia Moellmann, Barbara M Klinkhammer, Patrick Droste, et al.
Pageof 4